Abstract: The present invention includes compounds of formula (I) and methods for its preparation and treatment of disorders with activated peroxisome preoliferator-activated receptor gamma (PPARG), particularly cancer.

Abstract: A stand mixer includes a motor output shaft and a locking planetary output. The locking planetary output has a center shaft operably connected with the output shaft for driven rotation about a fixed axis, an agitator shaft mounted to the center shaft such that the agitator shaft moves around the fixed axis of the center shaft in a planetary arrangement, and a planetary gear centrally arranged about the fixed axis of the center shaft. A gear unit is rotatably fixed on the agitator shaft and is slidably mounted therewith to be moveable between a first position, in which the gear unit is engaged with the planetary gear, and a second position in which the gear unit is disengaged from the planetary gear and is engaged with a locking member.

Abstract: Methods and apparatus to determine user presence are disclosed. A disclosed example monitoring device to determine of a presence of a user in a metering environment includes a mount to couple the monitoring device to a wearable device to be worn by the user, the wearable device to receive content from a content device, a sensor to detect motion of the user, and a transmitter to transmit motion data pertaining to the detected motion of the user for the determination of the presence of the user.

Abstract: Methods and devices to detect analyte in body fluid are provided. Embodiments include positioning an analyte sensor in fluid contact with an analyte, detecting an attenuation in a signal from an analyte sensor after positioning during a predetermined time period, receiving the data corresponding to an analyte level, providing a notification on the user interface that comprises a request for a blood analyte measurement, receiving an indication, based on the blood analyte measurement, of an absence of the error condition, and in response to receiving the indication, configuring the user interface to report the data corresponding to the analyte level, where the user interface was previously configured to not report the data corresponding to the analyte level.

Abstract: Methods and system to provide glycemic control and therapy management based on monitored glucose data, and current and/or target HbA1C levels are provided.

Abstract: Apparatus, devices, systems, methods, and articles of manufacture are disclosed for watermarking with phase shifting. Example watermark decoding apparatus disclosed herein are to identify watermark components in a media signal, determine a phase shift pattern associated with the watermark components in the media signal, the phase shift pattern based on one or more phase references, and detect a symbol of a watermark based on the phase shift pattern, the watermark associated with the watermark components in the media signal.

Abstract: Methods and devices to detect analyte in body fluid are provided. Embodiments include positioning an analyte sensor in fluid contact with an analyte, detecting an attenuation in a signal from an analyte sensor after positioning during a predetermined time period, categorizing the detected attenuation in the analyte sensor signal based, at least in part, on one or more characteristics of the signal, performing signal processing to generate a reportable data associated with the detected analyte sensor signal during the predetermined time period, managing if and when to request additional reference signal measurements, and managing if and when to temporarily not display results.

Abstract: Methods, apparatus, and systems are disclosed for performing radio station monitoring using unmanned aerial vehicles. An example unmanned aerial vehicle disclosed herein includes at least one memory, computer readable instructions, and processor circuitry to execute the computer readable instructions to control the unmanned aerial vehicle to travel to a first radio station site to monitor a radio broadcast associated with the first radio station site, detect a watermark in the radio broadcast, and report at least one of the detected watermark or information associated with the detected watermark to a remote receiver.

Abstract: Method and system including displaying a first representation of a medication treatment parameter profile, displaying a first representation of a physiological profile associated with the medication treatment parameter profile, detecting a modification to a segment of the medication treatment parameter profile, displaying a modified representation of the medication treatment parameter profile and the physiological profile based on the detected modification to the segment of the medication treatment parameter profile, modifying an attribute of the first representation of the medication treatment parameter profile, and modifying an attribute of the first representation of the physiological profile are provided.

Abstract: Apparatus, devices, systems, methods, and articles of manufacture are disclosed for watermarking with phase shifting. An example watermark encoding apparatus includes memory, machine readable instructions, and processor circuitry to execute the instructions to select a plurality of frequencies for encoding a watermark symbol, apply a phase shift pattern to the plurality of frequencies, the phase shift pattern based on a phase reference, and embed in the plurality of frequencies the applied phase shift pattern in a media signal to encode the watermark symbol in the a media signal, and embed the phase reference into the media signal.

Abstract: Embodiments described herein relate to an analyte monitoring device having a user interface with a display and a plurality of actuators. The display is configured to render a plurality of display screens, including a home screen and an alert screen. The home screen is divided into a plurality of simultaneously displayed panels, with a first panel displays a rate of change of continuously monitored analyte levels in interstitial fluid, a second panel simultaneously displays a current analyte level and an analyte trend indicator, and a third panel displays status information of a plurality of components of the device. When an alarm condition is detected, the display renders the alert screen in place of the home screen, the alert screen displaying information corresponding to the detected alarm condition. Furthermore, the actuators are configured to affect further output of the analyte monitoring device corresponding to the detected condition.

Abstract: Methods and system to provide glycemic control and therapy management based on monitored glucose data, and current and/or target HbA1C levels are provided.

Abstract: Method and system including displaying a first representation of a medication treatment parameter profile, displaying a first representation of a physiological profile associated with the medication treatment parameter profile, detecting a modification to a segment of the medication treatment parameter profile, displaying a modified representation of the medication treatment parameter profile and the physiological profile based on the detected modification to the segment of the medication treatment parameter profile, modifying an attribute of the first representation of the medication treatment parameter profile, and modifying an attribute of the first representation of the physiological profile are provided.

Abstract: Method and apparatus for optimizing analyte sensor calibration including receiving a current blood glucose measurement, retrieving a time information for an upcoming scheduled calibration event for calibrating an analyte sensor, determining temporal proximity between the current blood glucose measurement and the retrieved time information for the upcoming calibration event, initiating a calibration routine to calibrate the analyte sensor when the determined temporal proximity is within a predetermined time period, and overriding the upcoming scheduled calibration event using the current blood glucose measurement are provided.

Abstract: Methods and apparatus to determine user presence are disclosed. A disclosed example monitoring device to determine of a presence of a user in a metering environment includes a mount to couple the monitoring device to a wearable device to be worn by the user, the wearable device to receive content from a content device, a sensor to detect motion of the user, and a transmitter to transmit motion data pertaining to the detected motion of the user for the determination of the presence of the user.

Abstract: Embodiments described herein relate to an analyte monitoring device having a user interface with a display and a plurality of actuators. The display is configured to render a plurality of display screens, including a home screen and an alert screen. The home screen is divided into a plurality of simultaneously displayed panels, with a first panel displays a rate of change of continuously monitored analyte levels in interstitial fluid, a second panel simultaneously displays a current analyte level and an analyte trend indicator, and a third panel displays status information of a plurality of components of the device. When an alarm condition is detected, the display renders the alert screen in place of the home screen, the alert screen displaying information corresponding to the detected alarm condition. Furthermore, the actuators are configured to affect further output of the analyte monitoring device corresponding to the detected condition.

Abstract: Method and apparatus for optimizing analyte sensor calibration including receiving a current blood glucose measurement, retrieving a time information for an upcoming scheduled calibration event for calibrating an analyte sensor, determining temporal proximity between the current blood glucose measurement and the retrieved time information for the upcoming calibration event, initiating a calibration routine to calibrate the analyte sensor when the determined temporal proximity is within a predetermined time period, and overriding the upcoming scheduled calibration event using the current blood glucose measurement are provided.

Abstract: Method and apparatus for optimizing analyte sensor calibration including receiving a current blood glucose measurement, retrieving a time information for an upcoming scheduled calibration event for calibrating an analyte sensor, determining temporal proximity between the current blood glucose measurement and the retrieved time information for the upcoming calibration event, initiating a calibration routine to calibrate the analyte sensor when the determined temporal proximity is within a predetermined time period, and overriding the upcoming scheduled calibration event using the current blood glucose measurement are provided.

Abstract: Method and apparatus for optimizing analyte sensor calibration including receiving a current blood glucose measurement, retrieving a time information for an upcoming scheduled calibration event for calibrating an analyte sensor, determining temporal proximity between the current blood glucose measurement and the retrieved time information for the upcoming calibration event, initiating a calibration routine to calibrate the analyte sensor when the determined temporal proximity is within a predetermined time period, and overriding the upcoming scheduled calibration event using the current blood glucose measurement are provided.

Abstract: Apparatus, devices, systems, methods, and articles of manufacture are disclosed for watermarking with phase shifting. Example watermark decoding apparatus disclosed herein are to identify watermark components in a media signal, determine a phase shift pattern associated with the watermark components in the media signal, the phase shift pattern based on one or more phase references, and detect a symbol of a watermark based on the phase shift pattern, the watermark associated with the watermark components in the media signal.